Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Metastasis | ASO Author Reflections

ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases

Author: Virginia Arrazubi, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

Patients with colorectal cancer liver metastases can benefit from hepatic resection. However, the probability of relapse is variable. In the era of major advances in surgical techniques and the availability of highly effective chemotherapy, research on biological prognostic factors is desirable.1‐3 …
Literature
1.
Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009;20(7):1223–9.CrossRef
2.
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230(3):309–18; discussion 318–21.CrossRef
3.
Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol 2013;20(7):2156–65.CrossRef
4.
Arrazubi V, Mata E, Antelo ML, et al. Circulating tumor cells in patients undergoing resection of colorectal cancer liver metastases. Clinical utility for long-term outcome: a prospective trial. Ann Surg Oncol. 2019;26:2805–11.CrossRef
Metadata
Title
ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases
Author
Virginia Arrazubi, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-08005-3

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue

Correction

Correction to: Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery

ASO Author Reflections

ASO Author Reflections: The Changing Role of Gene Expression Profiling in ER+/HER2− Breast Cancer

ASO Author Reflections

ASO Author Reflections: Mucocele-Like Lesions of the Breast—Excision or No Excision?

ASO Author Reflections

ASO Author Reflections: The Accurate Prognostic Evaluation and Optimal Treatment Strategy for Ampulla of Vater Carcinoma

ASO Author Reflections

ASO Author Reflections: Effect of Noncompliance in Lymph Node Dissection on the Long-Term Survival of Gastric Cancer Patients After Radical Gastrectomy

Endocrine Tumors

Reply to: Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma